|
Delayed
Japan Exchange
07:30:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,309.00 JPY | -3.47% |
|
-1.21% | -7.56% |
| 03-25 | Renascience Inc. cancelled the transaction announced on November 28, 2025 | CI |
| 03-05 | Renascience Inc. announced that it has received ¥459.972744 million in funding from CVI Investments, Inc. | CI |
| Market Cap | 18.03B 113M 97.15M 91.16M 83.32M 157M 10.8B 158M 1.07B 418M 5.46B 425M 416M | P/E 2025 |
118x | P/E 2026 | -71.8x |
|---|---|---|---|---|---|
| Enterprise Value | 14.63B 91.84M 78.82M 73.96M 67.6M 127M 8.76B 128M 868M 339M 4.43B 345M 337M | EV / Sales 2025 |
87.3x | EV / Sales 2026 | 290x |
| Free-Float |
43.01% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -3.47% | ||
| 1 week | -1.21% | ||
| Current month | -11.85% | ||
| 1 month | -15.28% | ||
| 3 months | -5.62% | ||
| 6 months | -28.04% | ||
| Current year | -7.56% |
| 1 week | 1,281 |  | 1,401 |
| 1 month | 1,101 | | 1,577 |
| Current year | 1,101 | | 2,185 |
| 1 year | 1,101 | | 2,342 |
| 3 years | 263 | | 3,310 |
| 5 years | 263 | | 3,310 |
| 10 years | 263 | | 3,310 |
| Manager | Title | Age | Since |
|---|---|---|---|
Toshio Miyata
PSD | President | 65 | 31/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Toshio Miyata
CHM | Chairman | 65 | 31/03/2020 |
Hiroaki Nojo
BRD | Director/Board Member | 67 | 31/05/2024 |
Akihiko Ito
BRD | Director/Board Member | 66 | 31/05/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.47% | -1.21% | -37.67% | +146.05% | 117M | |
| -3.59% | -2.96% | +71.06% | +114.83% | 1,100B | |
| -1.15% | -0.41% | +51.34% | +62.41% | 658B | |
| -1.09% | +1.54% | +26.67% | +79.22% | 470B | |
| -1.47% | +2.05% | +41.71% | +42.09% | 372B | |
| -0.90% | +1.29% | +25.62% | +41.75% | 304B | |
| -1.94% | +1.53% | +3.05% | +13.24% | 264B | |
| -0.43% | +3.54% | +52.65% | +71.75% | 239B | |
| -0.93% | +2.90% | -16.98% | -52.28% | 213B | |
| -0.46% | +3.24% | +29.73% | +92.67% | 184B | |
| Average | -0.89% | +3.14% | +24.72% | +61.17% | 380.3B | |
| Weighted average by Cap. | -0.34% | +2.21% | +42.86% | +68.25% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 132M 829K 711K 667K 610K 1.15M 79.05M 1.15M 7.83M 3.06M 39.93M 3.11M 3.04M | 68M 427K 366K 344K 314K 592K 40.72M 595K 4.03M 1.58M 20.57M 1.6M 1.57M |
| Net income | 113M 709K 609K 571K 522K 984K 67.67M 988K 6.7M 2.62M 34.19M 2.66M 2.61M | -301M -1.89M -1.62M -1.52M -1.39M -2.62M -180M -2.63M -17.86M -6.98M -91.06M -7.1M -6.94M |
| Net Debt | -1.8B -11.29M -9.69M -9.09M -8.31M -15.67M -1.08B -15.73M -107M -41.7M -544M -42.41M -41.48M | -3.4B -21.35M -18.33M -17.2M -15.72M -29.63M -2.04B -29.75M -202M -78.86M -1.03B -80.2M -78.45M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/08/26 | JP¥1,309.00 | -3.47% | 469,700 |
| 25/08/26 | JP¥1,356.00 | +1.95% | 232,100 |
| 24/08/26 | JP¥1,330.00 | +2.15% | 445,200 |
| 21/08/26 | JP¥1,302.00 | -4.82% | 420,600 |
| 20/08/26 | JP¥1,368.00 | +3.25% | 528,900 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4889 Stock
Select your edition
All financial news and data tailored to specific country editions
